Research ExplorerPublicationsSuccessful eradication of a FVIII inhibitor in a 60-year-old...

Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisolone.

Standard

Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisolone. / Holstein, Katharina; Marx, Guy; Lentz, Bernd; Bokemeyer, Carsten; Langer, Florian.

In: HAMOSTASEOLOGIE, Vol. 32 Suppl 1, 2012, p. 48-51.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Holstein, K, Marx, G, Lentz, B, Bokemeyer, C & Langer, F 2012, 'Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisolone.', HAMOSTASEOLOGIE, vol. 32 Suppl 1, pp. 48-51. <http://www.ncbi.nlm.nih.gov/pubmed/22960877?dopt=Citation>

APA

Holstein, K., Marx, G., Lentz, B., Bokemeyer, C., & Langer, F. (2012). Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisolone. HAMOSTASEOLOGIE, 32 Suppl 1, 48-51. http://www.ncbi.nlm.nih.gov/pubmed/22960877?dopt=Citation

Vancouver

Holstein K, Marx G, Lentz B, Bokemeyer C, Langer F. Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisolone. HAMOSTASEOLOGIE. 2012;32 Suppl 1:48-51.

Bibtex

@article{5522078d9fef4bcda50b2753bbcd1d57,
title = "Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisolone.",
abstract = "Development of FVIII inhibitors represents a major challenge in patients with mild haemophilia A (HA), because they tend to occur at an older age and classical immune tolerance induction appears to be less effective.",
keywords = "Humans, Male, Middle Aged, Treatment Outcome, Anti-Inflammatory Agents/therapeutic use, Blood Coagulation Factor Inhibitors/*blood, Factor VIII/*antagonists & inhibitors, Hemophilia A/*blood/diagnosis/*drug therapy, Prednisolone/*therapeutic use, Humans, Male, Middle Aged, Treatment Outcome, Anti-Inflammatory Agents/therapeutic use, Blood Coagulation Factor Inhibitors/*blood, Factor VIII/*antagonists & inhibitors, Hemophilia A/*blood/diagnosis/*drug therapy, Prednisolone/*therapeutic use",
author = "Katharina Holstein and Guy Marx and Bernd Lentz and Carsten Bokemeyer and Florian Langer",
year = "2012",
language = "English",
volume = "32 Suppl 1",
pages = "48--51",
journal = "HAMOSTASEOLOGIE",
issn = "0720-9355",
publisher = "Schattauer",

}

RIS

TY - JOUR

T1 - Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisolone.

AU - Holstein, Katharina

AU - Marx, Guy

AU - Lentz, Bernd

AU - Bokemeyer, Carsten

AU - Langer, Florian

PY - 2012

Y1 - 2012

N2 - Development of FVIII inhibitors represents a major challenge in patients with mild haemophilia A (HA), because they tend to occur at an older age and classical immune tolerance induction appears to be less effective.

AB - Development of FVIII inhibitors represents a major challenge in patients with mild haemophilia A (HA), because they tend to occur at an older age and classical immune tolerance induction appears to be less effective.

KW - Humans

KW - Male

KW - Middle Aged

KW - Treatment Outcome

KW - Anti-Inflammatory Agents/therapeutic use

KW - Blood Coagulation Factor Inhibitors/blood

KW - Factor VIII/antagonists & inhibitors

KW - Hemophilia A/blood/diagnosis/drug therapy

KW - Prednisolone/therapeutic use

KW - Humans

KW - Male

KW - Middle Aged

KW - Treatment Outcome

KW - Anti-Inflammatory Agents/therapeutic use

KW - Blood Coagulation Factor Inhibitors/blood

KW - Factor VIII/antagonists & inhibitors

KW - Hemophilia A/blood/diagnosis/drug therapy

KW - Prednisolone/therapeutic use

M3 - SCORING: Journal article

VL - 32 Suppl 1

SP - 48

EP - 51

JO - HAMOSTASEOLOGIE

JF - HAMOSTASEOLOGIE

SN - 0720-9355

ER -